Pfizer Says COVID Vaccine Will Cost as Much as $130 Per Dose When Government Contract Ends
OCT 22, 2022 | REPUBLISHED BY LIT: OCT 26, 2022
Pfizer is raising the “commercial list price” for its coronavirus vaccines.
The pharmaceutical company said Friday that the drug will cost between $110 to $130 per dose once its government contract ends, according to the Associated Press, though many will continue to receive the shot for free.
New prices could go into effect as soon as early 2023, depending on when the government phases out its own distribution program, the outlet said.
Angela Lukin, Pfizer’s global primary care & U.S. president, explained that increased prices are due to the costs of switching from multi-dose to single-dose vials and commercial distribution.
Lukin added that the new prices are still below the level of “what would be considered a highly effective vaccine,” per the AP.
Since the Affordable Care Act requires insurers to cover the costs of most recommended vaccines without charging out-of-pocket, many will pay little to nothing.
People with coverage through private insurance or public programs like Medicare and Medicaid will also likely pay nothing.
Pfizer also has an income-based assistance program to help uninsured people in the U.S. receive a vaccination.
The new estimated list price for Pfizer’s COVID vaccine is comparable to that of other adult vaccines, such as hepatitis and shingles, which can range from around $64 to $171, according to the Centers for Disease Control and Prevention.
Coronavirus vaccines and boosters are expected to remain free until the government ends its public health emergency declaration over the COVID-19 pandemic or depletes its federally acquired supply, according to a report published Tuesday by the Kaiser Family Foundation (KFF).